Lewis Joseph's Form 4 filing
Mirati Therapeutics, Inc. (MRTX) · filed Aug 15, 2023
- Accession no.
- 0000895345-23-000499
- Filed
- Aug 15, 2023, 9:38 PM ET
- Trade date
- Aug 11, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $35.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lewis JosephCIK 0001015747 | Other: See remarks |
| Fuglesang ChristopherCIK 0001465835 | Other: See remarks |
| Boxer Asset Management Inc.CIK 0001465836 | Other: See remarks |
| Boxer Capital, LLCCIK 0001465837 | Other: See remarks |
| Davis Aaron I.CIK 0001465914 | Other: See remarks |
| MVA Investors, LLCCIK 0001468223 | Other: See remarks |
| Dissanayake Shehan BharathaCIK 0001663609 | Other: See remarks |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | Common Stock | PPurchaseAcquired | +57,533 | $27.80 | +$1,599,417.4 | 287,866 | Indirect | |
| Aug 11, 2023 | Common Stock | PPurchaseAcquired | +1,201,440 | $27.80 | +$33,400,032 | 3,201,440 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The reporting persons may be deemed members of a group that beneficially owns more than 10% of the outstanding shares of common stock, $0.001 par value per share, of Mirati Therapeutics, Inc.